Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

  • STATUS
    Recruiting
  • participants needed
    60
Send
Updated on 19 February 2024

Summary

The natural history research on MS and the ability to use Magnetic Resonance Imaging (MRI) to monitor MS progression suggest that risk of relapse diminishes significantly as people age, especially those people who have not had relapses or MRI scan changes for at least 5 years. This study is designed to learn more about the safety of stopping MS medication in this group and compare their outcomes to other stable MS patients who continue taking their MS medications. 

You are being invited to participate in a research study because you have multiple sclerosis (MS) without recent disease activity, and have been on a stable MS medication for the past 5 years. 


Description

This study will have 2 different groups of research subjects like you. One of these groups will stay on their current MS medication, and one group will discontinue their medication. To decide which group you will be in, we will use a method of chance. This method is like flipping a coin or rolling dice. This is called "randomization". In order to participate in this study, you must be OK with being randomized to either group. (No matter which group you are randomized to, you will still be able to leave the study at any time or your doctor may remove you from the study as explained in the section·"can I be removed from this study?") If you join the study, you will be randomized to one of the 2 groups as described above. You will also have some extra assessments done at your regular routine MS clinic appointment or at a separate research appointment today. 

If you are randomized to the group to discontinue your medication, your doctor will provide instructions to safely discontinue your MS medication. 

This study will be conducted for two years. Up to 60 people from your area will participate in the study. Up to 300 people around the country will be in the study. 

FAQ


Details
Condition multiple sclerosis,ms
Age 18years - 99years
Clinical Study Identifier03073603
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.